UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Acute leukemia drug shows toxicity increase to particular genes
The Ministry of Food and Drug Safety said Monday it would add precautions o...
by Lee Hye-seon
|
2018-09-18 14:54
라인
AnC Bio, N&N Pharmaceuticals receive administrative warning
The Ministry of Food and Drug Safety said it has given an administrative wa...
by Lee Hye-seon
|
2018-09-17 14:59
라인
Philips reports reboot error in defibrillators
Philips said it has found a reboot error in some Efficia DFM100 defibrillat...
by Lee Hye-seon
|
2018-09-17 13:39
라인
Yuhan markets high-dose copy of Agrylin
Yuhan Corp. is to roll out a high-dose generic drug of Agrylin Cap. (ingred...
by Lee Hye-seon
|
2018-09-14 13:42
라인
Astellas wins nod for phase-3 trial on gastric cancer treatment
Astellas has obtained the regulatory approval to go ahead with a global pha...
by Lee Hye-seon
|
2018-09-11 10:38
라인
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control
The government has ordered Pfizer Korea to halt imports of three drugs for ...
by Lee Hye-seon
|
2018-09-07 16:24
라인
Biopharmaceuticals lead Korea’s drug output growth
Korea’s pharmaceutical output has exceeded 20 trillion won ($17.8 billion) ...
by Lee Hye-seon
|
2018-09-07 13:47
라인
Antihypertensive drug Kanarb tops output among local new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb marked the large...
by Lee Hye-seon
|
2018-09-07 11:08
라인
Antidiabetic combo Steglujan approved in Korea
MSD Korea said it has won approval to sell an antidiabetic combination drug...
by Lee Hye-seon
|
2018-09-06 11:55
라인
Korea to ban BPA in all food containers for children
The Korean government said it would prohibit the use of bisphenol A (BPA) i...
by Lee Hye-seon
|
2018-08-31 15:46
라인
Myungmoon Pharm’s valsartan additionally suspended
The government said it has completed testing all valsartan-using hypertensi...
by Lee Hye-seon
|
2018-08-23 15:10
라인
Lixiana faces patent challenge in substance, composition
Daiichi Sankyo’s anticoagulant treatment Lixiana (ingredient: edoxaban) has...
by Lee Hye-seon
|
2018-08-22 11:16
라인
TPLUS’ picture archiving system wins European certification
TPLUS, a Korean healthcare solution provider, said it has obtained Europe’s...
by Lee Hye-seon
|
2018-08-20 14:40
라인
MSD wins nod for antidiabetic SGLT-2 inhibitor
The Korean government has approved MSD’s Steglatro (ingredient: ertuglifloz...
by Lee Hye-seon
|
2018-08-20 11:34
라인
2 pharmaceuticals ordered to halt import drugs for poor packaging
Pfizer Korea and Bristol-Meyers Squibb Pharmaceutical Korea faced a one-mon...
by Lee Hye-seon
|
2018-08-17 15:10
라인
Psoriasis drug Tremfya may add indication for Crohn’s disease
Janssen Korea has obtained approval for clinical trials on plaque psoriasis...
by Lee Hye-seon
|
2018-08-14 12:07
라인
13 gadolinium contrast agents banned until year-end
The government said it would ban 13 linear gadolinium contrast agents used ...
by Lee Hye-seon
|
2018-08-13 14:36
라인
JW to launch drug combining Livaro, Ezetimibe
JW Pharmaceuticals has begun to develop a drug which combines two dyslipide...
by Lee Hye-seon
|
2018-08-09 11:59
라인
‘Peritoneal dialysis more cost-effective than hemodialysis’
Peritoneal dialysis (PD) is more cost-effective than hemodialysis (HD) for ...
by Lee Hye-seon
|
2018-07-23 11:53
라인
Il-yang gets 1-month suspension on quadrivalent flu vaccine
The government has suspended Il-yang Pharmaceutical’s manufacturing of Tera...
by Lee Hye-seon
|
2018-07-20 14:58
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top